Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

A Combined SAD and MAD Study to Investigate the Safety, Tolerability and Pharmacokinetic Profile of IFB-088

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03610334
Recruitment Status : Unknown
Verified August 2018 by InFlectis BioScience.
Recruitment status was:  Recruiting
First Posted : August 1, 2018
Last Update Posted : August 28, 2018
Sponsor:
Collaborators:
Qualissima
Assistance Publique des Hôpitaux de Marseille - Pharmacometry department
Stragen France
Information provided by (Responsible Party):
InFlectis BioScience

Results Submitted - Not Posted on ClinicalTrials.gov
Results information has been submitted to ClinicalTrials.gov by the sponsor or investigator, but is not yet publicly available (or "posted") on ClinicalTrials.gov. The submitted information may not be available if it is pending Quality Control (QC) Review by the National Library of Medicine (NLM) or if issues identified during QC review are being addressed or corrected by the sponsor or investigator. NLM's limited QC review assesses for apparent errors, deficiencies, or inconsistencies. NLM staff do not verify the scientific validity or relevance of the submitted information.
Recruitment Status : Unknown
Estimated Primary Completion Date : June 2019
Estimated Study Completion Date : July 2019
Submission Cycle Results Submitted to ClinicalTrials.gov Results Returned after Quality Control Review
1 January 5, 2021
January 26, 2021
2 August 30, 2021